Jebeles J A, Kissin I, Bradley E L
Anesth Analg. 1986 Jun;65(6):601-4.
In rat experiments, morphine-pentobarbital antinociceptive interaction affecting cardiac acceleration in response to somatic noxious stimulation was analyzed with the use of intrathecal and intracerebroventricular injections of morphine. Cardiac acceleration response was induced by tail compression, and heart rate was monitored by electrocardiogram. Pentobarbital, in a subanesthetic intravenous dose, antagonized the antinociceptive effect of morphine in relation to cardiac acceleration response when morphine was administered intracerebroventricularly. Without pentobarbital, morphine, 8 micrograms, almost completely blocked the cardiac acceleration response, which was only 1 +/- 1 beats/min. When pentobarbital (10 mg/kg intravenously) was administered in a combination with the same dose of morphine, the cardiac acceleration response was 29 +/- 3 beats/min (P less than 0.0001). In contrast, when morphine was administered intrathecally, the antagonism by pentobarbital of the cardiac acceleration response was absent. The results suggest that supraspinal mechanisms play a decisive role in morphine-pentobarbital antagonism in relation to cardiac acceleration response to somatic noxious stimulation.
在大鼠实验中,通过鞘内和脑室内注射吗啡,分析了吗啡-戊巴比妥对躯体伤害性刺激引起的心脏加速的抗伤害感受相互作用。通过尾部压迫诱导心脏加速反应,并通过心电图监测心率。当脑室内注射吗啡时,亚麻醉静脉剂量的戊巴比妥拮抗了吗啡对心脏加速反应的抗伤害感受作用。在没有戊巴比妥的情况下,8微克吗啡几乎完全阻断了心脏加速反应,该反应仅为1±1次/分钟。当戊巴比妥(静脉注射10毫克/千克)与相同剂量的吗啡联合使用时,心脏加速反应为29±3次/分钟(P<0.0001)。相比之下,当鞘内注射吗啡时,戊巴比妥对心脏加速反应没有拮抗作用。结果表明,脊髓上机制在吗啡-戊巴比妥对躯体伤害性刺激引起的心脏加速反应的拮抗作用中起决定性作用。